Heterodimer of b1-AR and b2-AR Optimizes b-AR Modulation
Heterodimer of b1-AR and b2-AR Optimizes b-AR Modulation
批准号:
7327060
负责人:
Rui-Ping Xiao
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
相似和不同的G蛋白偶联受体亚家族成员之间的分子间相互作用已在各种实验系统中得到证实。在这里,我们证明了在心脏、b1AR和b2AR中表达的主要b-肾上腺素能受体(bAR)亚型的异源二聚化及其生理相关性。在缺乏天然b1AR和b2AR的完整成年小鼠心肌细胞中,两种bAR亚型的共表达导致受体异二聚化,这一点可以通过它们的共免疫沉淀、光学分辨率下的共定位以及对亚型选择性配体的结合亲和力显著增加来证明。结果,肌细胞收缩对异丙肾上腺素(ISO)刺激的剂量-反应曲线左移了约1.5个数量级,细胞cAMP形成对ISO的反应也随之增强,表明bAR亚型的分子间相互作用导致这些受体对激动剂刺激的增敏。相反,b2ar的存在极大地抑制了共存的b2ar不依赖于配体的自发活性。因此,完整心肌细胞中b1AR和b2AR的异源二聚化产生了一种具有不同功能和药理特性的新型bar群体,从而增强了对激动剂刺激的信号传导效率,同时沉默了与配体无关的受体激活,从而优化了心脏收缩性的b-肾上腺素能调节。
英文摘要
Intermolecular interactions between members of both similar and divergent G protein-coupled receptor subfamilies have been shown in various experimental systems. Here, we demonstrate heterodimerization of predominant b-adrenergic receptor (bAR) subtypes expressed in the heart, b1AR and b2AR, and its physiological relevance. In intact adult mouse cardiac myocytes lacking native b1AR and b2AR, co-expression of both bAR subtypes led to receptor heterodimerization, as evidenced by their co-immunoprecipitation, co-localization at optical resolution, and markedly increased binding affinity for subtype-selective ligands. As a result, the dose-response curve of myocyte contraction to bAR agonist stimulation with isoproterenol (ISO) was shifted leftward by ~1.5 orders of magnitude, and the response of cellular cAMP formation to ISO was enhanced concomitantly, indicating that intermolecular interactions of bAR subtypes resulted in sensitization of these receptors in response to agonist stimulation. In contrast, the presence of b1AR greatly suppressed ligand-independent spontaneous activity of co-existing b2ARs. Thus, heterodimerization of b1AR and b2AR in intact cardiac myocytes creates a novel population of bARs with distinct functional and pharmacological properties, resulting in enhanced signaling efficiency in response to agonist stimulation while silencing ligand-independent receptor activation, thereby optimizing b-adrenergic modulation of cardiac contractility.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.yjmcc.2003.10.013
发表时间:
2004
期刊:
Journal of Molecular and Cellular Cardiology
影响因子:
5
作者:
[Xiao Rp;Balke Cw]
通讯作者:
Xiao Rp;Balke Cw
Pi3k Gs Signal Control During B2-adrenergic stimulation
-
批准号:6674194
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
Intracellular Acidosis-Activated p38 MAPK & Hypoxia
-
批准号:6969624
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
CaMKII-dB and CaMKII-dC Oppositely Regulate Cardiomyocyte viability
-
批准号:7591974
-
项目类别:
-
资助金额:$65.47万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
B-Arrestin2 Is Required for BAR Resensitization But Not
-
批准号:7327091
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
Cardiac Excitation-Contraction Coupling by p38 MAPK
-
批准号:6815451
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
B-Arrestin2 Is Required for BAR Resensitization But Not its Desensitization
-
批准号:7732333
-
项目类别:
-
资助金额:$37.94万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
B-Arrestin2 Is Required for BAR Resensitization But Not its Desensitization
-
批准号:7592069
-
项目类别:
-
资助金额:$46.76万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
Mitochondrial Protein HSG Is a Major Determinant of Oxid
-
批准号:7327023
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
Dysregulation of HSG Triggers Proliferative Disorders
-
批准号:6968763
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
Suppression of Beta-arrestin1 Phosphorylation and Function by Beta-arrestin2
-
批准号:7964066
-
项目类别:
-
资助金额:$20.33万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
Agonist Stereochemistry Determines Beta2-Adrenergic G Protein Coupling
-
批准号:7964073
-
项目类别:
-
资助金额:$22.59万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
Heterodimer of b1-AR and b2-AR Optimizes b-AR Modulation
-
批准号:7132347
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
CaMKII-aB Protects the Heart Against Oxidative-Stress In
-
批准号:7325047
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
PI3K Offsets b1-Adrenoceptor/PKA-Mediated Positive Inotr
-
批准号:6969617
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
Dysregulation of HSG Triggers Cardiomyocyte Apoptosis
-
批准号:7131125
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
Agonist Stereochemistry Determines b2-Adrenergic G Protein Coupling Preference
-
批准号:7732340
-
项目类别:
-
资助金额:$19.83万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
RGS2 Constitutes A Negative Regulator of Beta2-Adrenergic Gi Signaling
-
批准号:7732339
-
项目类别:
-
资助金额:$29.32万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
Beta1-adrenergic Apoptotic Signal Delivered By CaMKII
-
批准号:6814952
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
Identification and Characterization of A Novel Gene, HSG
-
批准号:6814956
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
CaMKII dB and dC have Opposing roles in regulating fate
-
批准号:7131113
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
国内基金
海外基金
登录
查看更多内容
一种适用于中药黄精中的基于环状适体酶的黄曲霉素B1比色检测方法研究
-
批准号:2026JJ80523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:蒲沁琳
-
依托单位:
基于GDF15调控探讨耳穴注射维生素B1改善妊娠剧吐的效应机制
-
批准号:2026JJ81414
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:符艳艳
-
依托单位:
c-Myb和Pu.1协同调节Lamin B1表达诱导
Pelger-Huët发生和促进sAML转化的机制
研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:刘伟
-
依托单位:
磁性Fe-MOF印迹微球对黄曲霉毒素B1预警分子AVN的靶向识别与吸附机
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李建美
-
依托单位:
MOFs拓扑结构调控的智能传感器构建及其在黄曲霉毒素B1预警中的应用
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李建美
-
依托单位:
补肾活血方上调THBS1促进BMSC分泌TGF-
B1增强“H血管-骨形成 ”偶联治疗骨关
节炎合并骨质疏松的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:潘建科
-
依托单位:
伏马毒素B1降解酶的脱毒机制及应用
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:蒋珺
-
依托单位:
适配体三维折叠构象对黄曲霉毒素B1 的SERS试纸条检测影响机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:孙悦
-
依托单位:
VDR介导VD3缓解伏马毒素B1诱导的草鱼肠道细胞凋亡的分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:张燿
-
依托单位:
蓝莓花色苷调节肠道菌群抑制黄曲霉毒素B1诱发肝细胞焦亡的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:刘韵乐
-
依托单位: